SCHEMBL6595078

SCHEMBL6595078

O=C(Nc1ccc(Cl)cc1)c1ncccc1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
PHGDH O43175 1/20 0.52
PLCG2 P16885 1/20 0.52
HTT P42858 3/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.50
TRPV1 Q8NER1 2/20 0.50
MDM2 Q00987 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
AURKB Q96GD4 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
GAA P10253 1/20 0.49
NCOA1 Q15788 1/20 0.49
NCOA3 Q9Y6Q9 1/20 0.49
THRB P10828 1/20 0.47
NPC1 O15118 2/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5794965 0.86 SMN1; SMN2 (0.61) MAPTHTTKMT2AMEN1ALDH1A1
SCHEMBL14284354 0.79 TLR7 (0.67) MAPTHTTALDH1A1LMNATRPV1
SCHEMBL7049057 0.78 ALDH1A1 (0.49) MAPTHTTKMT2AMEN1ALDH1A1
SCHEMBL3175503 0.77 GRM4 (0.72) MAPTHTTALDH1A1LMNASMN1; SMN2
SCHEMBL13962860 0.77 TRPV1 (0.64) MAPTHTTALDH1A1LMNATRPV1
SCHEMBL5226448 0.77 MAPT (0.78) MAPTHTTKMT2AMEN1ALDH1A1
SCHEMBL30236947 0.77 MAPT (0.78) MAPTHTTKMT2AMEN1ALDH1A1
SCHEMBL24377212 0.77 CTSD (0.57) MAPTHTTKMT2AMEN1ALDH1A1
SCHEMBL1231901 0.77 ALDH1A1 (0.51) MAPTHTTKMT2AMEN1ALDH1A1
SCHEMBL6105880 0.76 MAPT (0.52) MAPTHTTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed